Naloxone Hydrochloride Injection
Product Images NDC 70518-2725

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 70518-2725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Naloxone HCl 2mg 2ml (1mg mL) 70518 2725 01

Naloxone HCl 2mg 2ml (1mg mL) 70518 2725 01
This text provides information about Naloxone HCI, a medication used as an opioid antagonist. It comes in a prefilled syringe with a dosage of 2mg/2mL. The injection can be administered intravenously, intramuscularly, or subcutaneously. The medication is for single-use only and should not be reused or resterilized. Directions for use can be found in the package insert. The medication is manufactured by International Medication Systems located in El Monte, CA. The text also includes important warnings about potential glass breakage and subsequent injury if not handled properly. The medication should be stored at 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F) as per USP standards. The medication is repackaged by RemedyRepack Inc., Indiana, PA.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of a medication product called Naloxone HCI, available in 2mg/2mL (1mg/mL) injection form with a quantity of 10. It is intended for intravenous, intramuscular, or subcutaneous use as an opioid antagonist. It is a single-use pre-filled syringe and should not be reused or resterilized. The manufacturer is International Medication Systems located in El Monte, CA. The medication should be kept between 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F). The packaging includes a warning about the risk of glass breakage and injury if improperly engaged. Further directions for use are available on the package insert.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.